Profound Medical (PROF) Receivables - Net (2018 - 2026)

Profound Medical's Receivables - Net history runs 9 years deep, the most recent figure standing at $9.4 million for Q1 2026.

• On a quarterly basis, Receivables - Net rose 57.95% year-over-year to $9.4 million in Q1 2026; TTM through Mar 2026 was $9.4 million, a 57.95% increase from a year earlier, with the FY2025 full-year figure at $7.6 million, up 8.18% from the prior year.
• Receivables - Net grew to $9.4 million in Q1 2026 per PROF's latest filing, from $7.2 million in the prior quarter.
• Across five years, Receivables - Net topped out at $9.4 million in Q1 2026 and bottomed at $4.9 million in Q2 2025.
• The 5-year median for Receivables - Net is $7.1 million (2024), against an average of $7.0 million.
• Across the five-year window, Receivables - Net declined 3.33% in 2024 and soared 57.95% in 2026, its largest moves.
• Year by year, Receivables - Net stood at $6.3 million in 2022, then increased by 14.88% to $7.3 million in 2023, then dropped by 3.33% to $7.0 million in 2024, then grew by 2.2% to $7.2 million in 2025, then surged by 30.88% to $9.4 million in 2026.
• Per Business Quant, the three latest PROF Receivables - Net figures stand at $9.4 million (Q1 2026), $7.2 million (Q4 2025), and $8.2 million (Q3 2025).